| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.8 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |